Most Recent
B. Braun launches appeal in IV catheter patent case
Medical device maker B. Braun Melsungen is appealing a ruling that invalidated its intravenous catheter patents and dismissed allegations of infringement against rival Becton Dickinson.
Trade mark reputation not a factor in deceptively similar cases: Full Court
A judge applied the "wrong test" when he considered the reputation of a trade mark in an infringement case alleging the marks of rival meat processors were deceptively similar, a Full Federal Court has found.
Wyeth slams Merck Sharp & Dohme’s ‘baseless’ invalidity claim in vaccine trial
Pharmaceutical giant Wyeth has accused Merck Sharp & Dohme of a "baseless" patent invalidity case, saying on the second day of trial over the world's best selling vaccine that the development of its patented Prevnar 13 pneumococcal shot was anything but obvious, as its rival contends.
Merck Sharp & Dohme attacks Wyeth’s ‘broad’ patent claims for Prevnar 13 vaccine
A showdown between global pharmaceutical giants over the world's best selling vaccine began Monday in Federal Court, with Merck Sharp & Dohme claiming three patents for Prevnar 13 sold by Pfizer's Wyeth are invalid and that its own vaccine offers greater protection against pneumococcal bacteria.
Judge blocks Domain redirect in REA trade mark battle
Real estate advertiser REA Group has won an emergency injunction against Domain that blocks its rival from authorising the owner of the US website realestate.com to redirect Australian traffic to Domain.
IP exemptions to competition laws to be removed
IP owners need to consider the key or core licensing arrangements over the next six months and consider the competition law implications of conditions/restrictions in these licences, say Ayman Guirguis and David Howarth of K&L Gates.
Online property giant REA sues Domain for referral deal with realestate.com
Online real estate giant REA Group is suing competitor Domain Group over a referral arrangement with the US-based owner of the web address realestate.com, saying the deal amounts to trade mark infringement and misleading and deceptive conduct.
Sandoz infringed expired Lexapro patent, judge rules
Generic drug maker Sandoz has been found liable for patent infringement and misleading and deceptive conduct in a case by pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro, ending a battle that has raged for 15 years.
Catch Group takes another stab at trade mark opposition
Catch Group has appealed a decision from IP Australia that shot down its opposition to a trade mark by a rival online store.
Catch Group files trade mark lawsuit over ‘Catch of the week’ deals
E-retailer Catch Group has filed a trade mark lawsuit against a popular online classified ads provider over its "Catch of the week" and "Catch of the month" promotions.